cephalexin has been researched along with Disease Models, Animal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A; Tam, KY | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Li, J; Liu, YZ; Xu, ZH; Yan, CY; Yang, HY | 1 |
| Chang, E; Lefstein, KM; Mohan, A | 1 |
| Kim, Y; Kweon, MN; Lee, SH; Lee, YS; Park, YY; Yang, JY | 1 |
| Komori, H; Morokado, F; Nakanishi, T; Nishizawa, K; Tamai, I; Yoda, N | 1 |
| Sato, J; Terada, K; Watanabe, K | 1 |
| Kobashi, K; Okada, Y; Takeuchi, H; Tomoyoshi, T; Yoshida, O | 1 |
| Holm, SE | 1 |
| Bergeron, JM; Girard, D; Milisen, WB; Retsema, JA | 1 |
| de Sá Del Fiol, F; Groppo, FC; Rocha De Mattos Filho, T | 1 |
| Coenen, TM; Ratajczak, HV | 1 |
| Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
| Hatala, M; Liska, M; Modr, Z; Morávek, J; Prát, V | 1 |
| Edstrom, LE; Groskin, MG; Krizek, TJ; Robson, MC | 1 |
| Bailey, RR; Linton, AL; Turnbull, DI | 1 |
16 other study(ies) available for cephalexin and Disease Models, Animal
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Comparison of Antibacterial Effect of Cationic Peptide LL-37 and Cefalexin on Clinical Staphylococcus aureus-induced Infection after Femur Fracture Fixation.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cathelicidins; Cephalexin; Disease Models, Animal; Femoral Fractures; Fracture Fixation, Internal; Humans; Rabbits; Staphylococcal Infections; Surgical Wound Infection | 2020 |
Minocycline and Cephalexin in a Patient with Spastic Neuropathic Pain Secondary to Neurosarcoidosis.
Topics: Animals; Central Nervous System Diseases; Cephalexin; Disease Models, Animal; Humans; Hyperalgesia; Microglia; Minocycline; Muscle Spasticity; Neuralgia; Sarcoidosis | 2021 |
The resident pathobiont Staphylococcus xylosus in Nfkbiz-deficient skin accelerates spontaneous skin inflammation.
Topics: Adaptor Proteins, Signal Transducing; Animals; CD4-Positive T-Lymphocytes; Cephalexin; Dermatitis; Disease Models, Animal; Enrofloxacin; Humans; Immunoglobulin E; Mice; Nuclear Proteins; Sequence Analysis, DNA; Skin; Staphylococcal Infections; Staphylococcus; Symbiosis | 2017 |
Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Topics: Adenine; Animals; Antiporters; Cephalexin; Creatinine; Disease Models, Animal; Down-Regulation; Humans; Hyperuricemia; Kidney; Male; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxonic Acid; Pharmacokinetics; Rats; Rats, Wistar; RNA, Messenger; Uric Acid | 2019 |
Intestinal absorption of cephalexin in diabetes mellitus model rats.
Topics: Animals; Carrier Proteins; Cephalexin; Diabetes Mellitus, Experimental; Disease Models, Animal; Intestinal Absorption; Male; Peptide Transporter 1; Rats; Rats, Wistar; Rats, Zucker; Symporters | 2003 |
[Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin].
Topics: Animals; Cephalexin; Disease Models, Animal; Drug Therapy, Combination; Hydroxamic Acids; Male; Proteus Infections; Proteus mirabilis; Rats; Urease; Urinary Bladder Calculi; Urinary Tract Infections | 1983 |
Comparative efficacy of cefadroxil and penicillin versus beta-streptococcal infection in an experimental in-vivo model.
Topics: Animals; Cefadroxil; Cephalexin; Disease Models, Animal; Injections, Intramuscular; Penicillin G; Rabbits; Streptococcal Infections; Streptococcus pyogenes; Time Factors | 1982 |
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.
Topics: Abscess; Animals; Azithromycin; Cephalexin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Male; Mice; Mice, Inbred Strains; Rats; Roxithromycin; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1993 |
Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Ceftriaxone; Cephalexin; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Disease Models, Animal; Drug Therapy, Combination; Male; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcus aureus | 2000 |
Equal allergenic potency of beta-lactam antibiotics produced by chemical or enzymatic manufacturing--mouse IgE test.
Topics: Allergens; Amoxicillin; Animals; Anti-Bacterial Agents; Cephalexin; Disease Models, Animal; Drug Hypersensitivity; Female; Humans; Immunization; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Passive Cutaneous Anaphylaxis; Rabbits; Rats; Rats, Sprague-Dawley | 2001 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
[The effect of the combination of cephalexin with tobramycin on experimental pyelonephritis (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cephalexin; Disease Models, Animal; Drug Synergism; Female; Injections, Intramuscular; Pyelonephritis; Rats; Tobramycin | 1976 |
The efficacy of systemic antibiotics in the treatment of granulating wounds.
Topics: Animals; Anti-Bacterial Agents; Burns; Cephalexin; Cephaloridine; Cephalothin; Disease Models, Animal; Escherichia coli Infections; Granulation Tissue; Kanamycin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Staphylococcal Infections; Wounds and Injuries | 1974 |
Relative nephrotoxicity of cephalosporin antibiotics in an animal model.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Disease Models, Animal; Furosemide; Glycerol; Injections, Subcutaneous; Male; Rats; Rats, Inbred Strains | 1972 |